Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,533 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002529 | Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer(12-93) | completed | Phase 3 | 452 | ETOP IBCSG Partners FoundationNETWORK | 7 | Apr 4, 2013 | clinicaltrials |
| NCT00002784 | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer(15-95) | completed | Phase 3 | 344 | ETOP IBCSG Partners Foundation |
| 2 |
| Apr 4, 2013 |
| clinicaltrials |
| NCT00002823 | Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer | completed | Phase 3 | 3,300 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 29 | Mar 28, 2013 | clinicaltrials |
| NCT00122356 | Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment(BATMAN) | completed | Phase 3 | 303 | Barwon HealthOTHER_GOV | 1 | Mar 13, 2013 | clinicaltrials |
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00049998 | Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer | completed | Phase 3 | 760 | GlaxoSmithKlineINDUSTRY | 31 | Mar 4, 2013 | clinicaltrials |
| NCT01266811 | A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma | withdrawn | Phase 3 | 0 | Centocor, Inc.INDUSTRY | 14 | Jan 28, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 | clinicaltrials |
| NCT01209689 | A Study of Tocilizumab (RoActemra/Actemra) in Patients With Ankylosing Spondylitis Who Have Had an Inadequate Response to Previous Tumor Necrosis Factor (TNF) Antagonist Therapy | terminated | Phase 3 | 113 | Hoffmann-La RocheINDUSTRY | 19 | Jan 17, 2013 | clinicaltrials |
| NCT00410124 | RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib(RECORD-1) | completed | Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 10 | Jan 15, 2013 | clinicaltrials |
| NCT00699374 | Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer | terminated | Phase 3 | 1,075 | PfizerINDUSTRY | 23 | Jan 14, 2013 | clinicaltrials |
| NCT00065468 | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma(ARCC) | completed | Phase 3 | 626 | PfizerINDUSTRY | 25 | Oct 25, 2012 | clinicaltrials |
| NCT00561470 | Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen(VELOUR) | completed | Phase 3 | 1,226 | SanofiINDUSTRY | 28 | Sep 28, 2012 | clinicaltrials |
| NCT00917748 | Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF) | completed | Phase 3 | 84 | SanofiINDUSTRY | 1 | Sep 26, 2012 | clinicaltrials |
| NCT01013623 | Stage IV Surgery Versus Best Medical Therapy(STG4SURG) | terminated | Phase 3 | 12 | Saint John's Cancer InstituteOTHER | 5 | Sep 26, 2012 | clinicaltrials |
| NCT00003916 | Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma | completed | Phase 3 | 25 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Sep 24, 2012 | clinicaltrials |
| NCT00017277 | Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer | terminated | Phase 3 | 47 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Sep 24, 2012 | clinicaltrials |
| NCT00349336 | A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. | completed | Phase 3 | 64 | Hoffmann-La RocheINDUSTRY | 3 | Sep 18, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT01009593 | Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC) | terminated | Phase 3 | 1,035 | AbbottINDUSTRY | 29 | Sep 10, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00707304 | Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer(FORTIS-M) | completed | Phase 3 | 742 | AgennixINDUSTRY | 23 | Aug 21, 2012 | clinicaltrials |
| NCT00343616 | Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98 | completed | Phase 3 | 135 | ETOP IBCSG Partners FoundationNETWORK | 6 | Jul 27, 2012 | clinicaltrials |
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | completed | Phase 3 | 458 | ETOP IBCSG Partners FoundationNETWORK | 8 | Jul 27, 2012 | clinicaltrials |
| NCT00393939 | Study Of Sunitinib In Combination With Docetaxel Vs Docetaxel In Patients With Advanced Breast Cancer(SUN 1064) | completed | Phase 3 | 594 | PfizerINDUSTRY | 27 | Jul 19, 2012 | clinicaltrials |
| NCT00471146 | Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. | completed | Phase 3 | 630 | PfizerINDUSTRY | 24 | Jul 16, 2012 | clinicaltrials |
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 342 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 12 | Jul 2, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00312845 | Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma | completed | Phase 3 | 676 | Millennium Pharmaceuticals, Inc.INDUSTRY | 32 | Jun 25, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00471328 | Efficacy and Safety of Nilotinib (AMN107) Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib(ENEST) | completed | Phase 3 | 248 | Novartis PharmaceuticalsINDUSTRY | 13 | Jun 12, 2012 | clinicaltrials |
| NCT00241449 | A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer | completed | Phase 3 | 51 | AstraZenecaINDUSTRY | 26 | Jun 6, 2012 | clinicaltrials |
| NCT00420849 | A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma | completed | Phase 3 | 587 | Celgene CorporationINDUSTRY | 5 | May 21, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00003279 | Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer(SILVA) | completed | Phase 3 | 500 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Mar 6, 2012 | clinicaltrials |
| NCT00124748 | Efficacy of 400 Mg Versus 800 Mg Imatinib in Chronic Myeloid Leukemia in Chronic Phase Patients - TOPS (Tyrosine Kinase Inhibitor Optimization and Selectivity)(TOPS) | terminated | Phase 3 | 476 | Novartis PharmaceuticalsINDUSTRY | 6 | Feb 3, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT00174655 | BIG 02/98 Docetaxel - Breast Cancer | completed | Phase 3 | 2,887 | SanofiINDUSTRY | 21 | Nov 10, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00519090 | Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)(ENEST) | terminated | Phase 3 | 6 | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 7, 2011 | clinicaltrials |
| NCT00520676 | Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 3 | 260 | Eli Lilly and CompanyINDUSTRY | 6 | Aug 10, 2011 | clinicaltrials |
| NCT00568308 | Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma(PATHWAY) | terminated | Phase 3 | 600 | Progen PharmaceuticalsINDUSTRY | 10 | Jun 15, 2011 | clinicaltrials |
| NCT00006479 | Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Apr 18, 2011 | clinicaltrials |
| NCT00964210 | Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination(HPV) | completed | Phase 3 | 240 | Murdoch Childrens Research InstituteOTHER | 1 | Apr 15, 2011 | clinicaltrials |
| NCT00206219 | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) | completed | Phase 3 | 477 | AstraZenecaINDUSTRY | 25 | Jan 27, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00673205 | (Bicalutamide) Casodex vs Placebo in Non-metastatic Early Prostate Cancer(Capri) | completed | Phase 3 | 3,588 | AstraZenecaINDUSTRY | 16 | Dec 10, 2010 | clinicaltrials |
| NCT00715637 | Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study | unknown | Phase 3 | 420 | Antisoma ResearchINDUSTRY | 23 | Oct 13, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials